CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) : As previously reported on Form 8-K filed October 7, 2026, Holt & Patterson, our prior certifying public accountant resigned. Such firm confirmed that their resignation was not due to any disagreement on any matter related to our accounting practices or anything contained in a report issued by us. On October 27, 2026, CTT Pharmaceutical Holdings, Inc. signed an engagement letter with Zhanna Kelley, CPA as the Company’s PCAOB Auditor moving forward.
|
CTT Pharmaceutical Holdings, Inc. is a pharmaceutical technology company specializing in the development and commercialization of thin film oral drug delivery systems. The company utilizes a patented micelle-based thin film platform designed to provide rapid onset, enhanced patient convenience, and efficient absorption as an alternative to traditional dosage forms. Its business activities span pharmaceutical, therapeutic, and nutraceutical markets, with a specific focus on nicotine products and smoking cessation. CTT Pharmaceutical Holdings partners with academic institutions, including Johns Hopkins University, to conduct clinical trials and pursue regulatory preparedness. The company integrates scientific validation and scalable manufacturing to support product innovation and market entry in the United States. Summarised from the company's own disclosures |
Industry Biotechnology | Homepage cttpharmaceuticals.com |
| Sector Healthcare | IR page — | |
|
Tags
drug delivery, thin film technology, nicotine products, smoking cessation, oral dosage forms, micelle-based systems, Johns Hopkins University
|
Press page — |
Metrics
| Valuation | |
|---|---|
| Market cap | $ 3.404M |
| P/E | -0.48 |
| P/BV | 130.71 |
| P/S | — |
| P/OCF | -47.12 |
| P/FCF | — |
| Dividend yield | — |
| Turnover / mcap | — |
| Returns | |
|---|---|
| ROE | 38.8% |
| ROI | 38.8% |
| ROIC | -85.9% |
| Profit margin | — |
| Growth | |
|---|---|
| Revenue growing | — |
| Profits growing | Yes |
| Revenue up 3y | — |
| Revenue up 5y | — |
| Quality | |
|---|---|
| Profitable | Yes |
| Margin expanding | — |
| Buying back stock | No |
| Diluting (TTM) | — |
| Podcast bulls (TTM) | Sign up |
| Podcast bears (TTM) | Sign up |
| Podcast sentiment (TTM) | Sign up |
| Podcast sentiment % (TTM) | Sign up |
| News sentiment (TTM) | 0 |
| Quality score | 10.0% |
| Insiders | |
|---|---|
| Buys, 1w | Sign up |
| Buys, 1m | Sign up |
| Buys, 1y | Sign up |
| Sells, 1w | Sign up |
| Sells, 1m | Sign up |
| Sells, 1y | Sign up |
Sign up to see this company's insider trades
Sign up to see institutional holdings
Sign UpPodcast Mentions
Sign up to see podcast mentions and sentiment
Sign UpNews
Material events reported to the SEC on Form 8-K, newest first. The link opens the filing itself on EDGAR.
CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) is filing a response from the auditor of our last 8-K. The auditor agrees to what CTT Pharma previously filed.
CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) has parted ways with it’s auditor. There were no disagreements to accounting practices. The auditor is simply not handling SEC reporting companies moving forward. CTT Pharma will start looking for a new auditor and will reach out to another auditor the company has worked with before.
Prompts
Click prompts to add them under the company line, click again to take one out, then copy the result into your AI chat. Shared by Asian Century Stocks and Uncovered Thai Stocks. Thank you.
Company History
Name and ticker changes, and re-registrations under a new regulatory id. When a ticker stopped being used is not recorded, so former tickers are undated.
| Date | Change | Detail |
|---|---|---|
| Oct 7, 2014 | Renamed | MINDESTA INC. → CTT PHARMACEUTICAL HOLDINGS, INC. |
| Aug 11, 2011 | Renamed | INDUSTRIAL MINERALS INC → MINDESTA INC. |
| May 31, 2002 | Renamed | PNW CAPITAL INC → INDUSTRIAL MINERALS INC |